Investor Relations

Press Release

November 8, 2017

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017

More
October 31, 2017

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2017

More
September 25, 2017

Amphastar Announces Approval for Neostigmine Methylsulfate Injection, USP

More
September 20, 2017

Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection

More
August 30, 2017

Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference

More
August 9, 2017

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017

More
August 2, 2017

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017

More
July 24, 2017

Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

More
June 1, 2017

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

More
May 10, 2017

Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference

More
Youtube